DISPOSABLE CONTACT LENS-BASED OCULAR DELIVERY OF MOXIFLOXACIN : A NOVEL APPROACH by SHARMA, UMESH KUMAR
Vol 14, Issue 11, 2021
Online - 2455-3891 
Print - 0974-2441
DISPOSABLE CONTACT LENS-BASED OCULAR DELIVERY OF MOXIFLOXACIN : A NOVEL 
APPROACH
UMESH KUMAR SHARMA*
Department of Pharmaceutics, Mar Dioscorus College of Pharmacy, Thiruvananthapuram, Kerala, India.  
Email: umeshpanditjp@gmail.com
Received: 20 August 2021, Revised and Accepted: 05 October 2021
ABSTRACT
Objective: In the present research, the main objective was to investigate the possibility of designing, fabricating, and optimizing a disposable ocular 
film-based drug delivery system.
Methods: Moxifloxacin hydrochloride was loaded onto the prepared disposable ocular films by the soaking method.
Results: The drug loading conditions were studied, and it was found that the maximum drug loading was achieved in 3 hours at pH 6.5 of the drug 
solution. It was also observed that the drug loading efficacy and in vitro drug release profile can be monitored by varying the ocular film composition. 
The ocular films were then characterized for thickness uniformity, size uniformity, weight uniformity, swelling index, surface pH, breaking on 
elongation, folding endurance, bio-adhesive strength, transparency, drug loading efficiency, moisture content, morphological characteristics, and 
in vitro drug release profiles.
Conclusion: Based on the results, it was concluded that the developed disposable ocular films demonstrate a significant prolonged drug release 
within the therapeutic range of up to 12 h, which is promising as a novel disposable contact lens-based ocular drug delivery system.
Keywords: Disposable, Ocular films, Contact lenses, Chitosan, Activated silk fibroin, Snakeskin, Moxifloxacin, Ocular delivery.
INTRODUCTION
A common approach for treating ocular disorders is using topical 
eye drops in the form of solutions and suspensions because of their 
convenient and non-invasive application [1-3]. However, only 5% of the 
drug administered enters the intraocular tissues, and the remaining 
95% of the administered drug is wasted due to rapid drug clearance 
induced by a blink action, which also leads to poor drug bioavailability 
[4-6]. Therefore, frequent administration of eye drops is needed to 
maintain sustained therapeutic drug levels, which results in reduced 
patient compliance, increased local and systemic side effects, and 
increased treatment cost [1,7-9].
Disposable ocular films could be an interesting alternative approach 
to overcome these limitations [10-14]. The disposable ocular films 
could increase the residence time of the dosage form in the ocular 
cavity, leading to improved drug bioavailability, and minimised drug 
side effects, in addition to reduced treatment cost. Therefore, the idea 
of disposable contact lenses for ocular drug delivery is considered 
to be a non-invasive application that could eliminate multiple dose 
administrations and enhance patient compliance [15-17].
The poly (2-hydroxyethyl methacrylate) based conventional hydrogel 
contact lenses were examined for ocular drug delivery by soaking 
them in drug solution before insertion into the ocular cavity [18-20]. 
Although, they were found to be more effective than eye drops, their 
low drug loading efficacy and fast release characteristics were the 
limiting factors.
Pneumonia, conjunctivitis, endocarditis, tuberculosis, and sinusitis 
are a few types of infections which can be treated by moxifloxacin 
hydrochloride. Moxifloxacin belongs to the fluoroquinolone class of 
antibiotics and is represented as C21H24FN3O4. Mostly administered 
by mouth, IV or as eye drops, it shows a bioavailability of 86%, an 
elimination half-life of 12.1 h, and most of the administered drug is 
excreted from the body through urine and faeces [21,22].
The objective of this research was to explore the possibility of 
developing a film as biomaterials for disposable ocular film based 
ophthalmic drug delivery of Moxifloxacin hydrochloride. The effects 
of various combinations of additives and drug solution pH and time 
on drug loading, and drug release were studied. Properties such as 
transparency, thickness uniformity, size uniformity, folding endurance, 
bio-adhesive strength, drug loading efficiency, moisture content, and 
morphological characteristics were also investigated.
MATERIALS AND METHODS
Materials
The chitosan shrimp was obtained from Aura Biotechnologies Pvt. 
Ltd., Chennai, India, as gift sample. Bombyx mori raw silk yarns were 
obtained from Ashish Trading Company, Punjab as gift sample. 
Snakeskin pleated dialysis tube was obtained from Cole-polymer India, 
Mumbai as gift sample and moxifloxacin hydrochloride was obtained 
from Chromo Laboratories India Pvt. Ltd., as gift sample. Polyethylene 
glycol 400 (PEG400) was purchased from Merck, Hyderabad. All of the 
other chemicals and solvents were of the highest quality.
Preparation of activated silk fibroin
The raw silk yarns of B. mori were boiled with a 0.5% (w/v) sodium 
carbonate solution for 2 h to remove sericin, a gummy material that 
adheres to the silk fibre. Then, the degummed silk yarns were rinsed 
with warm RO water and dried at 40°C for 12 h. A 30:45:20:5 solution of 
calcium chloride (CaCl2), calcium nitrate (Ca(NO3)2), ethanol (C2H5OH), 
and water (H20) was prepared. The silk yarns were then heated in the 
prepared solution at 85–90°C until a gel-like solution formed. The 
resultant gel is dialyzed against RO water using a snakeskin pleated 
dialysis tube at room temperature for 72 h to eradicate salt residual, 
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and centrifuged at 15,000 rpm for 45 min to separate aggregates. The 
prepared activated silk fibroin solution was lyophilized and stored in 
self-sealing plastic pouches at 20°C for further use [23].
Fabrication of ocular films
The ocular films were prepared by the casting method. The 2% (w/v) 
solution of chitosan shrimp in acetic acid, the 2% (w/v) solution of 
activated silk fibroin gel in deionized water, and 25% (w/w) of PEG 
400 in the polymer matrix were mixed at 200 rpm for 30 min using 
a magnetic stirrer. The ocular films were prepared using different 
ratios of chitosan and activated silk fibroin solution (Table 1). The 
mixtures were then poured onto the glass molds and dried in a hot-
air oven at 60°C. The dried films were cut into 15 mm round shapes 
using a stainless steel cutting mold and dipped in 1M sodium hydroxide 
solution for 20 min, and the pH was neutralized by repeatedly rinsing 
with deionized water. The prepared ocular films were then immersed in 
0.01M phosphate buffer saline solution, pH 7.4 for 36 h and sterilized at 
121°C and 15 psi for 20 min in autoclave [24,25]. The sterilized ocular 
films were stored for further use.
Estimation of therapeutic dose
The estimated therapeutic dose of moxifloxacin was calculated. The 
moxifloxacin eye drop solution (0.5% w/v) is commonly prescribed 
at 1 drop 4 times a day. Assuming 1 drop is equal to 50 µl, the daily 
moxifloxacin eye drop dose is 200 µl, equivalent to 1000 µg of 
Moxifloxacin [26,19]. However, the ocular bioavailability of moxifloxacin 
through eye drop therapy is only 1%, which indicates that the 
therapeutic requirement of moxifloxacin is 10 µg/day [27,28]. However, 
several studies have proved that the bioavailability of drugs to target 
tissue is more than 50% through ocular drug delivery. Moxifloxacin 
ocular films have a therapeutic requirement of 20 µg/day, assuming 
50% bioavailability [29-31].
Drug loading to ocular films
A 0.5% solution of moxifloxacin hydrochloride (Fig. 1) in 0.01M 
phosphate buffer solution was prepared, and the solution was sterilized 
by the filtration method using a 0.22 m pore size membrane filter. Then, 
the prepared and autoclaved ocular films were soaked in 2 ml of 0.5% 
Moxifloxacin solution for 1–24 h. The pH of the drug solution was varied 
from 6.5 to 8.0 at room temperature in a laminar flow hood [32-34]. The 
fabricated drug-loaded ocular films were preserved for further use 
(Tables 2 and 3).
Physical evaluation of ocular films
The fabricated drug-loaded ocular films were evaluated for their 
physical and drug release properties. The key evaluation parameters 
are as follows:
Size uniformity
The uniformity of size is an important parameter, which determines the 
drug content of the fabricated ocular films. The size of the films was 
measured using a vernier caliper. The average size of the optimized 
batch was reported in Table 4.
Thickness uniformity
The uniformity of drug content in the lens and also its aesthetic value, 
to an extent, are determined by thickness uniformity. The thickness 
can be measured using a digital screw gauge (Mitutoyo MMO-25DS) at 
the center and at four positions around the perimeter of the hydrated 
films, and then the average thickness was calculated [35] and reported 
in Table 4.
Weight consistency
The fabricated lenses were weighed using a digital balance and weight 
variation was determined to ensure content uniformity, since deviation 
in uniform weight is due to a difference in the amount of either drug 
or the ocular film contents in an individual film. The average weight of 
optimized fabricated films was reported in Table 4.
Table 1: Composition of fabricated ocular films
Ingredients Formulation No.
OF‑01 OF‑02 OF‑03 OF‑04 OF‑05 OF‑06 OF‑07 OF‑08 OF‑09
Chitosan shrimps solution (%) 90 80 70 60 50 40 30 20 10
Activated silk fibroin gel (%) 10 20 30 40 50 60 70 80 90
PEG 400 (% w/w) 25 25 25 25 25 25 25 25 25
Table 2: Effect of time on drug loading capacity
Formulation Drug loading (µg) of ocular film
1 h 2 h 3 h 4 h 5 h 6 h 12 h 24 h
OF -01 05.32±0.56 07.32±0.42 09.75±0.32 09.78±0.44 09.78±0.35 09.78±0.40 09.76±0.21 09.75±0.23
OF -02 06.84±0.52 08.25±0.34 10.38±0.26 10.38±0.36 10.39±0.54 10.37±0.34 10.37±0.36 10.36±0.50
OF -03 07.58±0.63 09.56±0.52 12.86±0.52 12.88±0.28 12.89±0.36 12.87±0.66 12.87±0.40 12.86±0.36
OF -04 08.06±0.18 13.67±0.42 28.56±0.23 28.72±0.32 28.88±0.28 28.92±0.24 28.82±0.33 28.44±0.28
OF -05 09.53±0.51 12.23±0.51 18.89±0.28 24.62±0.25 24.62±0.33 24.61±0.48 24.60±0.52 24.59±0.52
OF -06 10.84±0.32 12.85±0.43 17.32±0.22 17.33±0.28 17.32±0.36 17.32±0.25 17.31±0.18 17.30±0.42
OF -07 11.56±0.51 12.52±0.36 18.56±0.18 18.56±0.44 18.56±0.38 18.55±0.24 18.54±0.32 18.53±0.22
OF -08 12.32±0.43 13.01±0.62 18.92±0.23 18.92±0.50 18.92±0.33 18.91±0.36 18.91±0.25 18.90±0.34
OF -09 12.89±0.71 13.94±0.35 19.23±0.44 19.23±0.32 19.22±0.26 19.21±0.52 19.20±0.55 19.92±0.40
CCL# 01.31±0.38 02.24±0.44 03.86±0.61 5.01±0.32 07.32±0.21 08.98±0.25 14.82±0.23 26.46±0.30
Condition: Moxifloxacin solution (0.5%), pH 6.5; SD: Standard deviation; n=3, #Commercial contact lenses
Fig. 1: Moxifloxacin hydrochloride
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Light transparency
The light transparency of the fabricated ocular films was determined 
using a ultraviolet (UV)-visible spectrophotometer. The hydrated films 
were glued to the quartz cuvette’s outer surface. The cuvette was 
placed in the spectrophotometer and the visible light transparency was 
measured at 381–780 nm [36] and reported in Table 4.
Swelling index
The swelling index is determined using stimulated tear fluid. 
Each fabricated ocular film was weighed and immersed in 5 mL 
of stimulated tear fluid. An increase in the weight of the film was 
determined at pre-set time intervals until a constant weight was seen. 
The degree of swelling was calculated using equation 1 and reported 
in Table 4.
Swelling index = Weight after swelling−Initial weight/Initial weight [1]
Moisture content
The moisture content of the fabricated ocular films may influence the 
mechanical strength and drug release behavior. Therefore, the moisture 
content of the film was estimated by keeping the film under vacuum 
desiccation until constant weight was obtained. The percentage 
moisture content was calculated [36] using equation 2 and was 
reported in Table 4.
%Moisture content = (Initial weight−Final weight/ 
                       Initial weight) × 100 [2]
Surface PH
To determine surface pH of ocular films, the fabricated films were 
left to swell for 1 h on the surface of the agar plate, prepared by 
dissolving 2% (w/v) agar in warmed isotonic phosphate buffer of 
pH 6.5 under stirring and then pouring the solution into the Petri 
dish and allowed to stand till gelling at room temperature. The 
surface pH was measured by means of pH paper placed on the surface 
of the fabricated contact lenses. The average surface pH was reported 
in Table 4.
Folding endurance
Folding endurance is the study to check the folding capacity of the 
ocular films when subjected to frequent extreme conditions such 
blinking of eye. The fabricated ocular films were folded and unfolded 
completely from the center several times until the film was broken. The 
number of folding and unfolding require to break the film completely 
was noted as folding endurance [37]. The average folding endurance 
was reported in Table 4.
Breaking on elongation
Break on elongation at break of the fabricated lenses were determined 
according to ASTM D882-12 using a universal testing machine with a 
load cell of 2 kg, a crosshead speed of 20 mm/min, and a gauge length 
of 10 mm [38,39] Table 4.
Bio‑adhesive strength
Construction of the test assembly
A student dispensing balance was used to construct the basic structure 
of the assembly to evaluate the bio-adhesive strength of the fabricated 
ocular film [40]. The dispensing balance’s right-side pan was replaced 
with a stainless-steel block attached with string, required a same 
weight as the left-side pan (Fig. 2).
Determination of adhesion force
The goat conjunctival membrane was washed and was tightly tied over 
a stainless-steel block; this assembly was attached to the right-side pan 
using a string, and another conjunctival membrane was tied to another 
stainless-steel block with the conjunctival mucosa side facing upward. 
The stainless-steel block with the conjunctival membrane was placed 
inside a glass beaker with a sufficient quantity of simulated tear fluid 
(STF) at 7.2 pH, such that the STF reaches the surface of the conjunctival 
membrane and keeps it moist. This beaker was placed under the right-
side pan of the balance. An ocular film was stuck onto the conjunctival 
membrane with a drop of water, and the assembly with the conjunctival 
membrane attached to the right-side pan was pressed over the insert 
placed over the conjunctival membrane stainless steel block placed 
inside the beaker. The assembly was kept in this position for 3 min, and 
then, weights were added gradually to the left pan till the ocular film 
separated from the mucosal surface completely. The excess weight of 
the pan that is the total, gives the measure of the force of detachment of 
the film in grams. From this, the bio-adhesion strength can be calculated 
by the formula force of adhesion (N) = F × 9.81. Where F is the excess 
weight added to the pan, a fresh portion of tissue was used for each 
measurement [40]. The average bio-adhesive strength of all the batches 
was reported in Table 4.
Drug content
The amount of drug loaded into the films was calculated from the 
difference between the amount of initial drug in the solution and 
the amount of drug remaining in the solution after film soaking. The 
amount of free drug remaining in the solution was determined using 
a UV-visible spectrophotometer at 293 nm, and the results were noted 
in Table 4.
Surface morphology
The surface morphology and cross section of the moxifloxacin loaded 
lenses were examined by a scanning electron microscope (SEM) to 
confirm drug loading. The samples were sputter-coated with platinum 
using a plasma sputter coater to obtain fine images and minimize 
electron charging on the surface (Figs. 3 and 4).
In vitro drug release studies
In vitro drug release studies were carried out at 37°C±1°C. The 
moxifloxacin loaded ocular films were placed into a pipette tip, 
Table 3: Effect of drug solution pH on drug loading capacity
Formulation Drug loading (µg) of ocular film
pH 6.5 pH 7.0 pH 7.5 pH 8.0
OF -01 09.75±0.32 09.12±0.28 08.84±0.42 08.84±0.42
OF -02 10.38±0.26 09.74±0.30 09.13±0.40 09.13±0.40
OF -03 12.86±0.52 12.01±0.24 11.46±0.19 11.46±0.19
OF -04 28.56±0.23 28.12±0.28 27.63±0.32 27.63±0.32
OF -05 18.89±0.28 18.42±0.36 17.62±0.47 17.62±0.47
OF -06 17.32±0.22 17.02±0.42 16.67±0.28 16.67±0.28
OF -07 18.56±0.18 18.28±0.23 17.86±0.30 17.86±0.30
OF -08 18.92±0.23 18.48±0.32 17.94±0.27 17.94±0.27
OF -09 19.23±0.44 19.01±0.28 18.43±0.36 18.43±0.36
Condition: Moxifloxacin solution (0.5), Time 3 h; SD: Standard deviation; n=3 Fig. 2: Assembly to determine bio‑adhesive strength
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with a fluid cavity of 50 µl. The pipette tip was then inserted into a 
disposable sample collection tube and fed using STF (pH 7.4) at a flow 
rate of 10 ml/min using a micro drop infusion set. Sodium chloride 
0.67 g, sodium bicarbonate 0.2 g, calcium chloride 0.008 g, in 100 ml 
of deionized water were the contents of STF. At predetermined time 
intervals (1–12 h), the disposable sample collection tube was taken 
and replaced with a new sample collection tube. The amount of drug 
released in sample collection tube was then determined using a UV-
visible spectrophotometer at 293 nm (Table 5). The release profile of 
a drug was evaluated by plotting graphs of cumulative drug release 
versus time (Fig. 5).
RESULTS AND DISCUSSION
The ocular films were fabricated following the optimum conditions. The 
fabricated ocular films fulfil the requirements of the materials standard 
for disposable contact lenses as ocular drug delivery.
Fabrication of ocular films
The ocular films were fabricated using different ratio of chitosan shrimp 
solution and activated silk fibroin along with PEG 400 (Table 1).
Drug loading capacity
Due to its cost effectiveness and simplicity, the soaking method is the 
most conventional and effective way of loading a drug into the ocular 
films. To attain this, the fabricated ocular films were dipped in 2 ml of 
0.5% Moxifloxacin solution and the drug was allowed to get adsorbed 
into the ocular films’ surface and core. It was found that the drug 
loading capacity of the ocular films depends on three important factors, 
such as the composition of the film, dipping time, and drug solution pH. 
To study the effect of drug loading time, the films were soaked in 0.5% 
moxifloxacin solution, pH 6.5, with varying soaking time from 1 to 24 h 
(Table 2). It was found that the drug loading to ocular films increased 
by increasing the soaking time from 1 to 12 h and reached equilibrium 
at 3 h for all fabricated films, compared to conventional contact lenses 
which require a high drug loading time of 12–24 h (Fig. 6).
The drug loading capacity of the ocular films was studied at a varying 
pH range of drug solution from 6.5 to 8.0 for 3 h. The fabricated ocular 
films were soaked in 2 ml of 0.5% moxifloxacin solution with a pH range 
of 6.5 to 8.0 for 3 h. It was noted that the increasing drug solution pH 
would decrease the drug loading capacity of the ocular films (Table 3). 
All the fabricated ocular films represent the maximum drug loading at 
pH 6.5 and the minimum drug loading at pH 8.0.
The observations suggest that the moxifloxacin was loaded onto all 
fabricated ocular films. This indicates the inter-molecular interaction, 
likely due to hydrogen bonding and ionic interaction, among the drug 
and the film forming agents. However, it was found that the drug loading 
was increased with increasing the ratio of activated silk fibroin in the 
film. The formulation no. OF-01 shows the lowermost drug loading 
capacity. On the other hand, the formulation no. OF-04 exhibited the 
highest drug loading capacity, which may be due to the high content 
of activated silk fibroin resulting in a high porous portion. Accordingly, 
the high porous portion offers more space in the film, which leads to 
enhanced drug adsorption in the film’s surface and core.
Physical evaluation of the ocular films
The fabricated ocular films were evaluated for physical properties 
and compared with typical commercial contact lenses. The physical 
properties of the drug loaded ocular showed no significant difference 
when compared with commercial contact lenses (Table 4). The 
fabricated ocular films were found to be in a range of 14.98±0.10 to 
15.01±0.10 mm round with uniformity in size and compliant with 
commercial contact lenses of similar size. They have a comparable 
thickness range between 99.06±0.34 and 100.04±0.43 µm, with 
commercial contact lenses of 50–200 µm.
The fabricated ocular films were weighed within a range limit 
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transparency of between 91% and 93%, which meets the visual 
requirements of contact lenses. The swelling index of the was found 
to be 12.8±1.0 and 15.42 ±1.0%, moisture content of fabricated ocular 
films was observed in a range of 54.23±1.0 and 66.12±1.0%, due to its 
high moisture content, these films may be more comfortable to wear. 
The surface pH was noted in a range of 6.4±0.1–6.8±0.1 which indicated 
the comfort of the ocular cavity without any irritation. The folding 
endurance of 234–289 and elongation at break 69±1.0 and 73±1.0% 
satisfy the stiffness and flexibility requirements of contact lenses. The 
bio-adhesive strength of the fabricated ocular films was observed 
in a range of 2456.34±0.53 and 6132.45±0.64, which indicates the 
better retention time of the ocular films in the ocular cavity to provide 
prolonged release of the drug.
The drug content of the fabricated medicated ocular films was 
determined and was found in a range of 7.32±0.56 and 56.14±0.41 µg 
(Fig. 7). The SEM monograph of the surface and cross section of the 
fabricated ocular films shows the absorption of drug on the film 
surface as well as in the core Fig. 1. From the SEM monograph, it 
was found that the drug was attached to the surface of the film in 
formulation no. OF-01, while the drug was observed both on the outer 
surface and in the inner core of formulation no. OF-04. Notably, the 
higher ratios of activated silk fibroin resulted in higher drug loading 
to the ocular films.
In vitro drug release studies
As per the drug loading study, all the fabricated ocular films were 
immersed in a 2 ml 0.5% solution of moxifloxacin, pH 6.5, for 3 h 
before conducting the in vitro drug release studies. The in vitro drug 
Fig. 4: Scanning electron microscope of OF‑09 and commercial 
contact lenses
Fig. 3: Scanning electron microscope of OF‑01 and OF‑04
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Fig. 6: Drug loading capacity of ocular films versus time
Fig. 7: Drug loading capacity of ocular films versus pH
release studies were conducted for 12 h and are reported in Table 5. 
The graph of cumulative percentage released and time were plotted 
in the figure, which demonstrates that the formulations no. OF-01 to 
OF-03 showed a slow release that is 08.54±0.23 µg to 97.12±0.18 µg in 
12 h release studies which indicates that high chitosan content slows 
the drug release due to locking of the drug in the chitosan matrix and 
unavailability of porosity in the films (Figs. 8 and 9).
Whereas the formulation no. OF-04 containing 60:40 of chitosan and 
silk fibroin shows an ideal drug release pattern and the drug release 
range is 11.28±0.24 µg to 98.86±0.24 µg in 12 h, which explains the 
phenomenon that the drug absorption locations affect the drug release 
profile significantly. Noticeably, the drug located on the film surface is 
immediately released into the media, contributing to the fast release 
phase. Drugs that stayed in the inner core, on the other hand, took a bit 
longer to dissolve and diffuse to the outer surface, resulting in a longer 
release phase. Further, the formulations no. OF-05 to OF -09 showed 
fast release due to the very high porosity of the film, which resulted 
due to the high content of silk fibroin. Thus, the formulation OF-04 was 
selected as the optimized formulation.
CONCLUSION
Moxifloxacin hydrochloride was successfully loaded into the 
fabricated ocular film by the soaking method with a short loading 
time of 3 h. The drug loading did not affect the essential contact lens 
properties of the fabricated ocular films. Basically, the composition of 
ocular films altered the drug loading capacity and the drug released 
profile. Increasing the silk fibroin content enhances the drug loading 
capacity of the film but shortens the release duration. Consequently, 
an ideal released characteristic within a therapeutic level of up to 12 h 
was observed with the 60:40 (Chitosan: Silk fibroin). The fabricated 
ocular films are promising novel biomaterials for producing 
medicated disposable contact lenses-based ophthalmic delivery 
systems for daily use, which will be beneficial in reducing drug 
dose related side effects, administration frequency, and improving 
patient compliance as compared to conventional eye drops and eye 
ointments.
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